Natural killer (NK) cells are large granular lymphocytes thought to be important in the host's early immune response to viral infection and malignant transformation. NK cells proliferate and display enhanced cytotoxic activity in response to the T cell growth factor, interleukin 2 (IL-2). Stem cell factor or steel factor (SF) is the ligand for the c-kit receptor, and when combined with other hematopoietic growth factors, SF synergistically promotes the proliferation and differentiation of bone marrow stem cells. In the present study we show the c-kit receptor to be uniquely expressed on a subset of resting human NK cells (CD56b~s ht) which constitutively expresses both the high affinity IL-2 receptor (IL-2R) and the intermediate affinity IL-2R. Other lymphocyte populations, including CD56 dim NK cells, did not appear to express the c-kit receptor. Within the CD56bng ht NK cell subset, SF alone had no obvious effect on proliferation or cytotoxic activity. SF was shown to significantly augment the proliferative effect of IL-2, and caused a marked shift in the dose-response curve at IL-2 concentrations that selectively saturate the high affinity IL-2R. The potentiating effect of SF on NK cell proliferation was dependent on IL-2 binding to the high affinity IL-2R, and was blocked by a monoclonal antibody directed against the c-kit receptor. SF did not enhance proliferation at higher IL-2 concentrations that saturate the intermediate affinity IL-2R, nor did SF enhance IL-2-induced cytotoxic activity. Together, these data indicate that SF and IL-2 act synergistically to directly augment the proliferative capacity of a unique human NK cell subset constitutively expressing the high affinity IL-2R and the c-kit receptor. The implications of these findings on NK cell development and the host's early immune response to pathogen invasion are discussed.
N
'K cells are a distinct population of large granular lymphocytes that appear to have an important role in the host's early immune response to viral infection and malignant transformation. NK cells show a proliferative and enhanced cytotoxic response to IL-2, a lymphocytotropic hormone produced by activated T cells that is essential in normal immune responses (for a review see reference 1). Indeed, unlike the vast majority of other lymphocyte populations found in resting human peripheral blood, most NK cells constitutively express one or two functional isoforms of the human IL-2R. 90% of NK cells can be identified by their low density expression of the CD56 antigen (CD56 dim) and express an intermediate affinity IL-2tL, now known to be composed of at least two subunits, IL-2fl and IL-2"y. A minor subset of NK cells, identified by its high density expression of the CD56 antigen (CD56bnsht), expresses both the intermediate affinity IL-2R and the high affinity IL-2R, composed of three subunits that are noncovalently linked to form a heterotrimer (IL-2RotBT) (2) (3) (4) (5) . Saturation of the high affinity IL-2R expressed on the CD56bng ht NK population with low concentrations of IL-2 (i.e., 1-100 pM) results in a profound proliferative response with only modest enhancement of cytotoxic activity. The intermediate affinity IL-2R, when saturated by higher concentrations of IL-2 (i.e., 1-10 nM), significantly enhances cytotoxic activity in both the CD56b~ig ht and CD56 a~m NK cell populations, yet does not result in any enhancement of proliferation (2) . Thus, despite both functional IL-2R isoforms being constitutively expressed on the CD56 bright NK cells and both isoforms possessing the subunits important for signal transduction and internalization (5), significant proliferation only occurs via the heterotrimeric high affinity IL-2Kotfl%
The protooncogene c-kit encodes a transmembrane tyrosine kinase receptor that belongs to a superfamily that indudes the receptors for insulin, platelet-derived growth factor, epidermal growth factor, and CSF-1 (6) . Within the hematopoietic system the c-kit receptor is expressed on normal bone marrow cells at various stages of maturation (7) . Steel factor (SF) or stem cell factor is a ligand for the c-kit receptor (8, 9) , and together, c-kit receptor and SF are considered to play a major role in the regulation of human hematopoiesis. Whereas SF alone has only a modest effect on stem cell proliferation (10), SF has been observed to exhibit potent synergistic activity with virtually all of the known hematopoietic growth factors, including erythropoietin (Epo), IL-3, GM-CSF, G-CSF, and IL-6, resulting in increased colony formation of both primitive and lineage-specific hematopoietic progenitor cell populations (11, 12) . These hematopoietic growth factors specifically bind to their respective receptors which all belong to the hematopoietin receptor superfamily that also includes IL-2RB and IL-2R3' (5, 13). Because SF has been shown to augment the proliferative effects mediated via the hematopoietin receptors constitutively expressed on hematopoietic stem cells, we hypothesized that SF may also potentiate functional responses of IL-2 in human NK cells that constitutively express IL-2R. In the present study, we demonstrate that the CD56bng ht NK cell appears unique among resting human lymphocytes in its constitutive expression of the c-kit receptor, and have performed a functional characterization of the interactions between SF and IL-2 on this lymphocyte population.
Materials and Methods
raAbs. Nonreactive rain before the addition of Ig2 (2). For c-kit receptor blocking studies, anti-c-kit receptor mAb (14) was used as affinity-purified sterile ascites and was added 15 min before the addition of SF. Isotype control mAbs, affinity purified in an identical fashion to experimental reagents, were used in blocking studies. Cell number and viability were determined by trypan blue dye exclusion. Cells incubated in "medium only" were in RPMI 1640 supplemented with 10% human AB serum.
Cytotoxicity Assays. Chromium release assays were performed in triplicate as described (2) ELISA for SE A sandwich-type ELISA to determine the concentration of SF in RPMI 1640 medium containing 10% human AB serum was kindly performed by L. G. Bennett at Amgen, Inc.
(Thousand Oaks, CA) (15).
StatisticalAnalysis. Results of experimental points obtained from
multiple experiments were reported as the mean _+ 1 SE. Significance levels were determined by two-sided student's t test analysis. target cells after exposure to IL-2 (LAK activity) (1) . To show that CD56 b~t c-kit + cells possessed NK activity and were responsive to IL-2, CD56bri~ t c-kit + and CD56brig ht c-kit-cells were sorted by FACS | and plated immediately in a cytotoxicity assay against the NK-sensitive K562 cell line, or incubated overnight in 10 nM IL-2 and then plated in a cytotoxicity assay against the NK-resistant COLO 205 cell line The results, shown in Fig. 2 , demonstrate that CD56b~ ht c-kit + cell possesses significant NK and LAK activity, although less than the CD56b~ t c-kit-fraction. The effect of SF on NK and LAK activity was also evaluated. When resting CD56b'~ ht NK cells were cultured in a high ('~7 nM or 250 ng/ml) concentration of SF alone, cytotoxicity against K562 tumor cell targets was not significantly increased over that seen in medium alone Furthermore, the addition of "~7 nM SF to cultures containing low (10 pM or •2.3 U/ml) or high (1 nM or "o230 U/ml) concentrations of IL-2 did not enhance the LAK activity mediated via the high or intermediate affinity IL-2R, respectively (data not shown).
Results

Selective Expression of the c-kit Receptor on the CD56 ~ght
Effects of SF on IL-2-induced NK Cell Proliferation. Highly purified CD56b~ t NK cells isolated from resting human peripheral blood failed to demonstrate any significant enhancement of proliferation when incubated in the presence of medium plus SF. It has been shown previously that 10 pM of IL-2 selectively saturates the high affinity IL-2P, constitutively expressed on the CD56 h~ht subset of NK cells and induces a significant proliferative response (2, 3), as evidenced by the 10-fold increase in [3H]thymidine incorporation over baseline seen in Fig. 3 A. The simultaneous addition of '~7 rum SF and 10 pM IL-2 resulted in a proliferative response that was over threefold higher than that seen with IL-2 alone (p <0.01), and 30-fold higher than baseline levels of proliferation with medium or SF alone (Fig. 3 A) . Consistent with this, the number of cells in wells containing SF and IL-2 was 65% greater than the number of cells in wells containing IL-2 alone, when enumerated at 96 h. 
IL-2 Concentration (pM)
The effect of SF on I1,2-induced proliferation of CD56brig ht NK cells. (A) The effect of SF on Ib2-induced proliferation is synergistic and dose dependent. CD56b~s ht NK cells were purified from fresh PBL, and cultured for 72 h in the presence of medium, ~7 nM SF (250 ng/ml), 10 pM 11,2 (2.3 U/ml), 10 pM I1,2 and '~0. At 10 pM IL-2, the enhancing effect of SF on proliferation of the CD56b~ig ht population was shown to be dose dependent, with significant increases in IL-2-induced proliferation consistently being seen at SF concentrations between 70 and 100 pM (data not shown), and a two-to threefold increase in proliferation at SF concentrations between 0.7 and 7 nM (Fig. 3 A) The addition of SF to CD56brig ht NK ceils cultured at increasing concentrations of IL-2 resulted in a distinct shift of the IL-2 proliferative dose-response curve (Fig. 3 B) . In the absence of SF, CD56brig ht NK cells required 25 pM IL-2 to achieve 50% of the maximal proliferative response, whereas in the presence of ,'~7 nM SF, CD56b"s ht NK cells achieved a comparable response with only 3 pM IL-2. Importantly, SF induced this synergistic proliferative response only at those concentrations of IL-2 that saturate the high affinity IL-2R (i.e., 1-100 pM) (16). CD56 bright cells cultured in the presence of SF and higher concentrations of IL-2 (i.e., 1-10 pM), which saturate both the high and the intermediate affinity IL-2R expressed on these cells, did not show further increases in proliferation when compared with that seen at 100 nM IL-2. CD56 dim NK cells, which only express the intermediate affinity IL-2R and do not appear to express the c-kit receptor, did not show any significant proliferation in the presence of SF and 1 nM IL-2 (data not shown).
Requirement of High Affinity IL-2R Binding. To investigate whether IL-2 binding to the high affinity IL-2R was required for the potentiating effect of SF on CD56bng h~ proliferation, cells were cultured in the presence or absence of anti-Tac (anti-CD25) mAb. The addition of anti-Tac mAb to CD56b~ig h~ cells cultured in 10 pM IL-2 abrogates the proliferative response by inhibiting the binding of IL-2 to the high affinity IL-2R (2, 16). As can be seen in Fig. 4 A, CD56b~ig ht NK cells incubated in the presence of anti-Tac mAb and 10 pM IL-2 achieved only 10.2% of the proliferative response achieved by cells incubated with control mAb and 10 pM IL-2. Likewise, CD56b~ig h~ NK cells incubated in the presence of antiTac mAb, 10 pM IL-2 and '~7 nM SF achieved only 19.6% of the proliferative response of cells incubated in control mAb, IL-2, and SF. This proportional reduction in the presence of anti-Tac mAb indicates that the potentiating effect of SF on CD56b~g ht NK cell proliferation is dependent on IL-2 binding to the high affinity IL-2R.
Functional Characterization oft-kit Receptor Expression on the CD56~g ht NK Cells. The anti-c-kit receptor mAb YB5.B8 inhibits the binding of SF to the c-kit receptor (14) . Additional functional studies were performed on the CD56bng h~ NK cells in the presence of anti-c-kit receptor mAb to determine if effects of SF were mediated via the constitutively expressed c-kit receptor. CD56bng h~ cells purified from resting PBL were incubated in the presence of either the isotype control mAb or anti-c-kit receptor mAb before the addition of 10 pM IL-2 and "~140 pM (5.0 ng/ml) of SF. As can be seen from Fig. 4 B, the presence of the anti-c-kit receptor mAb abrogated the enhancing effect of SF on IL-2-induced proliferation in the CD56b~s ht NK subset (p ~<0.006). SF therefore appears to mediate its effect via the c-kit receptor. Importantly, Fig. 4 B also shows that cells incubated in 10 pM IL-2 and concentrations of SF which approximate those found in vivo (3.3. ng/ml or ",~90 pM) (15) , demonstrate a proliferative response that is significantly greater than that seen with cells incubated in 10 pM IL-2 and 10% human AB serum (0.3 ng/ml of SF) (p ~<0.03).
Discussion
In the present study, we report that the CD56brig ht subset of human NK cells constitutively expresses functional receptors encoded by the c-kit protooncogene. Whereas the expression of the c-kit receptor has previously been found on a broad range of hematopoietic and nonhematopoietic cell types (14) , expression on resting human lymphocytes has not previously been reported. By flow cytometric analyses, c-kit receptor expression on lymphocytes appears to be restricted to the CD56bns ht NK subset. The studies demonstrating significant NK and LAK activity within the CD56bas ht c-kit + fraction provide evidence that this population fulfills the functional definition of NK cells. The CD56bag ht NK subset represents ~<2% of human PBL, and also appears to be unique in its constitutive expression of the high affinity IL-2R (2, 3) . Given the synergy of SF with other ligands of the hematopoietin receptor superfamily (11, 12) , we investigated whether the SF-c-kit receptor interaction would enhance the functional responses of the CD56b~ig ht NK subset mediated via the IL-2R.
The results presented here demonstrate that SF significantly enhances the IL-2-induced proliferative response of the CD56b~ig ht NK subset, and does so in a dose-dependent fashion. Whereas SF alone has no effect on proliferation, it causes a pronounced shift in the IL-2 dose-response curve at concentrations of IL-2 that selectively saturate the high affinity IL-2R (i.e., 1-100 pM). CD56brig ht NK cells cultured in the presence of "~7 nM SF required approximately eightfold less IL-2 to achieve 50% of their maximal proliferative response. In addition, the inhibition of IL-2 binding to the high affinity IL-2R with anti-Tac mAb, which results in a profound reduction in IL-2-induced proliferation, proportionally reduced the proliferation achieved with SF and IL-2. Together, these data strongly suggest that signal transduction via the IL-2-high affinity IL-2K interaction is a prerequisite for the enhanced proliferative effect mediated by SF.
The fact that SF did not augment a proliferative response mediated via the intermediate affinity IL-2K at high concentrations of IL-2 is not surprising, since the intermediate affinity IL-2K expressed on CD56brig ht or CD56 dim NK cells does not transduce a significant proliferative signal when fully saturated by IL-2 (2). However, SF did not augment the NK cytolyric response which is enhanced on all NK cells after activation of the intermediate affinity IL-2R by IL-2 (2). SF may therefore potentiate an intracellular signal that is specific for IL-2-induced proliferation and not IL-2-enhanced cytotoxicity.
The expression of the c-kit receptor is most abundant on the early hematopoietic progenitor populations and declines with terminal myeloid and erythroid differentiation (7). Nagler et al. (17) performed a phenotypic and functional analysis of CD56brig ht (CD16-) and CD56 dim (CD16 +) human NK cells, and proposed that the CD56 basht NK subset is less differentiated than the CD56 aim subset. The unique expression of the c-kit receptor on the CD56 bright NK subset would lend further support to this proposal, and may help to explain why the CD56hi8 ht c-kit + fraction displays less NK and LAK activity than the CD56 bright c-kit-fraction. The proliferation studies performed in the presence of the anti-ckit receptor mAb provide strong evidence that the potentiating effect of SF on CD56bag ht NK ceils is indeed mediated via the c-kit receptor. In vitro concentrations of SF which approximate those found in vivo (15) were found to significantly augment the IL-2-induced proliferative response of CD56 bright NK cells when compared with that seen with IL-2 alone. SF may therefore have physiologic relevance for the CD56b~is ht NK functional response in vivo when, during viral infection, soluble IL-2 is produced by activated T cells. Recent work by Miller et al. (18) suggests that IL-2 and stromal cell factors such as SF are required for NK cell development from CD34+DR -progenitor populations in vitro. The constitutive expression of the c-kit receptor on this NK subset may therefore also serve to promote intimate contact with marrow stromal cells expressing the active transmembrahe form of SF during its maturation in vivo.
In a recent clinical trial, we have demonstrated that the CD56bng h~ subset of human NK cells can undergo a profound selective expansion in vivo during a prolonged continuous infusion of low dose IL-2. Serum concentrations of IL-2 during these infusions ranged between 10 and 200 pM, optimal for saturation of the high affinity IL-2R (19) . The results of our in vitro study reported here suggest that the presence of SF in normal human serum may be an important component of this selective immune modulation in vivo, and that the concomitant administration of exogenous SF might produce a more rapid expansion of this NK cell subset at a significantly lower concentration of IL-2. Further elucidation of the mechanisms involved in this potentiating effect, as well as other functional consequences of SF on human NK cells, should lend additional insights into the role(s) of this growth factor in NK cell development and the host's normal immune response, and may provide important information for the successful design of future clinical trials.
